Emanuela Anastasi

Pubblicazioni

Titolo Pubblicato in Anno
PANC-1 cell line as an experimental model for characterizing PIVKA-II production, distribution, and molecular mechanisms leading to protein release in PDAC INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
Efficacy and safety of BNT162b2 mRNA vaccine in a cohort of 90 transfusion dependent thalassemia patients TRANSFUSION MEDICINE 2024
Association between serum levels of GDF-15, suPAR, PIVKA-II, sdLDL and clinical outcomes in hospitalized COVID-19 patients INTERNAL AND EMERGENCY MEDICINE 2024
Combined PIVKA II and Vimentin-Guided EMT Tracking in Pancreatic Adenocarcinoma Combined Biomarker-Guided EMT Tracking in PDAC CANCERS 2024
Emerging horizons on molecular and circulating biomarkers in pancreatic adenocarcinoma FRONTIERS IN ONCOLOGY 2024
Ovarian reserve in patients with Sjögren's syndrome: a cross-sectional study CLINICAL RHEUMATOLOGY 2024
SARS-CoV-2 infection in pregnancy. Clues and proof of adverse outcomes INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023
SARS-CoV-2 infection in pregnancy. Clues and proof of adverse outcomes INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023
Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023
Anti-N SARS-CoV-2 assays for evaluation of natural viral infection JOURNAL OF IMMUNOLOGICAL METHODS 2023
Ovarian Cancer Biomarkers in the COVID-19 Era INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023
Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions FRONTIERS IN IMMUNOLOGY 2023
Vitamin K deficiency in newly diagnosed prostate cancer patients CLINICAL CHEMISTRY AND LABORATORY MEDICINE 2023
PIVKA II diagnostic threshold in italian pancreatic ductal adenocarcinoma patients: a single centre experience LIGAND ASSAY 2023
Angiogenic factors as prognostic markers in neuroendocrine neoplasms ENDOCRINE 2022
Rapid Weight Loss, Central Obesity Improvement and Blood Glucose Reduction Are Associated with a Stronger Adaptive Immune Response Following COVID-19 mRNA Vaccine VACCINES 2022
New Analytical Approach for the Alignment of Different {HE}4 Automated Immunometric Systems: An Italian Multicentric Study JOURNAL OF CLINICAL MEDICINE 2022
Humoral Immune response to Comirnaty ({BNT}162b2) {SARS}-Cov2 {mRNA} vaccine in Thalassemia Major patients MICROBES AND INFECTION 2022
What is the Hidden Biological Mechanism Underlying the Possible SARS-CoV-2 Vertical Transmission? A Mini Review FRONTIERS IN PHYSIOLOGY 2022

ERC

  • LS1_2
  • LS1_4

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Identificazione di nuove proteine coinvolte neli procesi neoplastici. Studio di biomarcatori per diafnosi differenziale, diagnosi e follow-up dei tumori solidi con particolare interesse per il cancro epiteliale dell' ovaio e adenocarcinoma pancreatico.

Studio della risposta umorale nei pazienti COVID-19 e nei soggetti spttoposti a vaccinazione.

Keywords

ovarian cancer
pancreatic cancer
COVID-19

Progetti di Ricerca

Laboratori di ricerca

Automazione analitica e spettrometria di massa in oncologia e farmaco-tossicologica

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma